All In Biotech

Drug Trial Radar · NCT05398445

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD)

Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 769 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

769

Actual

Start

May 31, 2022

Primary completion

Nov 28, 2024

Study completion Jan 13, 2025

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jun 1, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Conditions

  • Atopic Dermatitis

Interventions

  • RocatinlimabDrug

    Participants will receive Rocatinlimab subcutaneously.

  • PlaceboDrug

    Participants will receive a placebo subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Who Achieved Validated Investigator's Global Assessment for AD (vIGA-AD) 1 Response With Presence of Only Barely Perceptible Erythema or vIGA-AD 0 Response (Revised Investigator's Global Assessment [rIGA] 0/1) at Week 24Time frame: Baseline and Week 24
  2. Number of Participants Who Achieved ≥ 75% Reduction From Baseline in Eczema Area and Severity Index Score (EASI 75) at Week 24Time frame: Baseline and Week 24

Locations

202 sites in 21 countries. Site status is shown where the registry gives one.

  • Cahaba Dermatology and Skin Health Center

    Birmingham, Alabama

  • Alliance Dermatology and Mohs Center

    Phoenix, Arizona

  • Anaheim Clinical Trials

    Anaheim, California

  • First OC Dermatology

    Fountain Valley, California

  • Kaiser Permanente - Glendale Medical Center

    Glendale, California

  • Long Beach Research Institute

    Long Beach, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Dermatology Research Associates

    Los Angeles, California

  • Cura Clinical Research

    Sherman Oaks, California

  • IMMUNOe Research Centers

    Centennial, Colorado

  • Skin Care Research Incorporated

    Boca Raton, Florida

  • Palm Beach Dermatology Group

    Delray Beach, Florida

  • Global Research Associates

    Homestead, Florida

  • Healthy Life Research

    Miami, Florida

  • Savin Medical Group LLC

    Miami Lakes, Florida

  • Kirsch Dermatology LLC

    Naples, Florida

  • Pure Skin Dermatology and Aesthetics

    Orlando, Florida

  • Industrial Medicine Associates Ima Clinical Research Inc

    St. Petersburg, Florida

  • Genesis Clinical Research LLC

    Tampa, Florida

  • Treasure Valley Medical Research

    Boise, Idaho

  • DeNova Research

    Chicago, Illinois

  • Dundee Dermatology

    West Dundee, Illinois

  • The Indiana Clinical Trials Center PC

    Plainfield, Indiana

  • Institute for Asthma and Allergy

    Chevy Chase, Maryland

  • Continental Clinical Solutions, LLC

    Towson, Maryland

  • Henry Ford Health System

    Detroit, Michigan

  • Onyx Clinical Research

    Flint, Michigan

  • Dermatology and Skin Cancer Center of Lees Summit

    Lee's Summit, Missouri

  • Jubilee Clinical Research Inc

    Las Vegas, Nevada

  • Allcutis Research, Llc - Portsmouth

    Portsmouth, New Hampshire

  • Continental Clinical Solutions - Cherry Hill

    Cherry Hill, New Jersey

  • Industrial Medicine Associates Ima Clinical Research Inc

    Hartsdale, New York

  • Sadick Research Group

    New York, New York

  • Dermatology Specialists of Charlotte

    Charlotte, North Carolina

  • Onsite Clinical Solutions

    Charlotte, North Carolina

  • Wilmington Dermatology Center

    Wilmington, North Carolina

  • The Skin Surgery Center for Clinical Research

    Winston-Salem, North Carolina

  • Optima Research

    Boardman, Ohio

  • ClinOhio Research Services

    Columbus, Ohio

  • Unity Clinical Research

    Oklahoma City, Oklahoma

Showing 40 of 202 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.